Swift Biosciences, Inc. is a biotechnology startup founded in 2010, dedicated to developing advanced molecular biology reagents for research and diagnostic applications. Based in Ann Arbor, Michigan, the company focuses on pioneering innovative solutions in the biotechnology and healthcare industries. Swift Biosciences' commitment to advancement was demonstrated through its $4.00M Venture Round investment on 01 November 2018. Despite the absence of specific information regarding the last investment's investors, the company's dedication to innovation in molecular biology reagents showcases its potential for growth and impact in the industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $4.00M | - | 01 Nov 2018 | |
Series D | $12.20M | 1 | 30 Jun 2017 | |
Series C | $3.00M | 3 | Fletcher Spaght, Inc. | 15 Apr 2016 |
Venture Round | $1.50M | - | 10 Sep 2015 | |
Series B | $7.00M | 3 | Fletcher Spaght, Inc., DFJ Mercury | 17 Oct 2013 |
No recent news or press coverage available for Swift Biosciences.